Dyne Therapeutics, Inc. (DYN) vs Neogen Corporation (NEOG)
A side-by-side comparison of Dyne Therapeutics, Inc. and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DYN
Dyne Therapeutics, Inc.
$15.18HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NEOG
Neogen Corporation
$12.16HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — DYN vs NEOG
growth of $100 · dividends reinvested · last 6yDYN -35.4% (-7.0%/yr)NEOG -66.0% (-16.5%/yr)DYN compounded faster over this window
DYN NEOG
DYN vs NEOG: by the numbers
- •DYN is the larger company ($2.83B vs $2.65B market cap).
- •Both run net losses; DYN's is the smaller (0.00% vs -0.91% net margin).
Metrics side by side
Valuation
| Metric | DYN | NEOG |
|---|---|---|
| Forward P/E | N/A | 39.21 |
| P/S ratio | N/A | 3.05 |
| P/B ratio | 4.04 | 1.27 |
| EV / EBITDA | N/A | 32.51 |
Profitability
| Metric | DYN | NEOG |
|---|---|---|
| Gross margin | 0.00% | 46.93% |
| Operating margin | 0.00% | -2.49% |
| Net margin | 0.00% | -0.91% |
| ROE | -73.97% | -0.38% |
| ROIC | -58.28% | -0.68% |
Growth (annualized)
| Metric | DYN | NEOG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.19% |
| Total return CAGR (5Y) | -0.38% | -21.13% |
Frequently asked
- How have DYN and NEOG total returns compared?
- Over the past 5 years, DYN delivered -0.38% and NEOG delivered -21.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.